Genomic and transcriptional profiling stratifies VQ myeloma lines into two clusters with distinct risk signatures and drug responses is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01AI079087-04
PLC?s in B cell biology and autoimmunity
National Institutes of Health
Grant: 5R01CA212413-05
Syndecan-1 (CD138) and its synstatins: targeting invasion, survival and angiogenesis in myeloma
National Institutes of Health
Grant: 1R01HL130724-01A1
B cell responses in heparin-induced thrombocytopenia
National Institutes of Health
Grant: 5R01CA152108-04
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
National Institutes of Health
Grant: 5T32GM081061-02
Graduate Training in Cellular and Molecular Pathogenesis of Human Diseases
National Institutes of Health
Grant: 1R01CA252937-01
Tumor matrix remodeling in anti-myeloma immunity and immunotherapy
Fields of Study
Sustainable Development Goals